Capital Pro-Egaux Inc., through its wholly owned subsidiary technique d'usinage Sinlab Inc, has received the Germany court deci
30 September 2012 - 1:07AM
PR Newswire (Canada)
LACHENAIE, QC, Oct. 2, 2012 /CNW Telbec/ - Capital Pro-Égaux Inc.
(the "Company") reports that on Friday, September 28(th)
2012, the "Company" has been advised, through the attorneys of its
wholly owned subsidiary Technique d'usinage Sinlab Inc., that the
German court has decided in favor of the plaintiff Nobel Biocare at
the conclusion of the oral hearing on the subject of the nullity
proceedings in the matter of Sinlab's German Technobar patent no
1,043,960, filed by Nobel in August of 2010. The written DETAILED
decision will be communicated, by the German court, in the next two
to three months and the "Company" will have a one month period to
request an appeal and a three months period to file its written
appeal document. Kindly note that further to our review of the
German oral hearing decision, as reported by our German attorneys,
that the "Company" will be appealing this decision in due time and,
that the recent German decision has no bearing on the 22 other
patents owned by the "Company" in Europe, Canada and the USA. About
Pro-Égaux Inc. Pro-Égaux through its wholly owned subsidiary,
Technique d'usinage Sinlab Inc., is a company based in Lachenaie,
Quebec, specializing mainly in the conception and design of
titanium products to be used in the dental prosthesis restoration
industry. "Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release." CAPITAL PRO-EGAUX INC. CONTACT: Capital
Pro-Egaux Inc. Pierre Desormeau President Tel.: (514) 616-0612 Fax:
(450) 226-1923 pierredesormeau@sympatico.ca
Copyright
Capital Pro Egaux (delisted) (TSXV:CPE.H)
Historical Stock Chart
Von Aug 2024 bis Sep 2024
Capital Pro Egaux (delisted) (TSXV:CPE.H)
Historical Stock Chart
Von Sep 2023 bis Sep 2024
Echtzeit-Nachrichten über Capital Pro Egaux (delisted) (TSX Venture Börse): 0 Nachrichtenartikel
Weitere Capital Pro Egaux News-Artikel